Silo Pharma, Inc. (SILO)
NASDAQ: SILO · IEX Real-Time Price · USD
0.947
-0.023 (-2.39%)
At close: Jul 2, 2024, 3:58 PM
0.945
-0.002 (-0.18%)
After-hours: Jul 2, 2024, 7:08 PM EDT

Silo Pharma Stock Forecast

SILO's stock price has decreased by -52.9% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Silo Pharma stock has a target of 10, which predicts an increase of 956.19% from the current stock price of 0.95.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $10 $10 $10 $10
Change +956.19% +956.19% +956.19% +956.19%
* Price targets were last updated on Aug 28, 2023.

Analyst Ratings

According to 1 stock analyst, the rating for Silo Pharma is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Aug '23
Strong Buy 1
Buy 0
Hold 0
Sell 0
Strong Sell 0
Total 1

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Laidlaw & Co.
Laidlaw & Co.
Strong Buy
Initiates
$10
Strong Buy Initiates $10 +956.19% Aug 28, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
73.44K
from 72.10K
Increased by 1.86%
Revenue Next Year
73.44K
from 73.44K
EPS This Year
-0.57
from -1.20
EPS Next Year
-0.71
from -0.57
Year 20192020202120222023202420252026
Revenue
40.57K-71.26K72.10K72.10K73.44K73.44K73.44K
Revenue Growth
---1.18%-1.86%--
EPS
-2.00-3.001.30-1.71-1.20-0.57-0.71-0.73
EPS Growth
--------
Forward PE
--------
No. Analysts -----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High 75,600 75,600 75,600
Avg 73,440 73,440 73,440
Low 70,560 70,560 70,560

Revenue Growth

Revenue Growth 202420252026
High
4.9%
2.9%
2.9%
Avg
1.9%
- -
Low
-2.1%
-3.9%
-3.9%

EPS Forecast

EPS 202420252026
High -0.59 -0.74 -0.76
Avg -0.57 -0.71 -0.73
Low -0.55 -0.69 -0.71

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.